We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DNA market cap is 1.71B. The company's latest EPS is USD -0.4148 and P/E is -27.53.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 66.4M | 98.29M | 80.7M | 80.57M | 55.43M |
| Operating Income | -675.73M | -224.51M | -215.75M | -185.67M | -190.18M |
| Net Income | -669.06M | -176.54M | -204.97M | -173.32M | -302.89M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 313.84M | 477.71M | 251.46M |
| Operating Income | -5k | -1.91B | -2.25B | -770.83M |
| Net Income | -5k | -1.83B | -2.1B | -892.87M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 1.87B | 2.54B | 2.42B | 2.29B | 2.03B |
| Total Liabilities | 430.96M | 803.04M | 809.62M | 788.41M | 773.71M |
| Total Equity | 1.44B | 1.74B | 1.61B | 1.5B | 1.25B |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.25M | 2.07B | 2.54B | 1.67B |
| Total Liabilities | 1.23M | 503.61M | 803.04M | 568.19M |
| Total Equity | 20k | 1.57B | 1.74B | 1.1B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -147.5M | -252.2M | -90.59M | -164.12M | -237.67M |
| Investing | -97.13M | -67.39M | -19.41M | -30.64M | -34.02M |
| Financing | -2.6M | 95.34M | -888k | -2.27M | -2.58M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -253.82M | -252.2M | -295.5M |
| Investing | N/A | -73.26M | -67.39M | -80.69M |
| Financing | N/A | 1.53B | 95.34M | -3.22M |
| Market Cap | 1.71B |
| Price to Earnings Ratio | -27.53 |
| Price to Sales Ratio | 97.77 |
| Price to Cash Ratio | 26.04 |
| Price to Book Ratio | 22.4 |
| Dividend Yield | - |
| Shares Outstanding | 2.15B |
| Average Volume (1 week) | 52.9M |
| Average Volume (1 Month) | 33.19M |
| 52 Week Change | -35.37% |
| 52 Week High | 2.545 |
| 52 Week Low | 0.7403 |
| Spread (Intraday) | 0 (0.18%) |
| Company Name | Ginkgo Bioworks Holdings Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ginkgobioworks.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
